Elevance Health, Inc.
ELV · Healthcare
$403.04
Cargando gráfico…
Noticias
Últimos titulares de esta acción
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
UnitedHealth (UNH) has surged 38.8% over six months as medical-cost pressures ease and confidence improves. The company's medical care ratio fell to 85.3%, medical costs declined 2%, and 2026 EPS estimates rose 21.2% to $19.82. Despite the rally, UNH trades below its five-year median valuation and analyst price targets, suggesting further upside potential. The stock carries a Zacks Rank #2 (Buy) rating.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
The iShares U.S. Healthcare Providers ETF (IHF) is a passively managed fund launched in 2006 that tracks the Dow Jones U.S. Select HealthCare Providers Index. With $1.25 billion in assets, a competitive 0.37% expense ratio, and a Zacks ETF Rank of 2 (Buy), it offers diversified exposure to healthcare providers. Year-to-date performance is up 20.18%, with a medium risk profile (beta of 0.72). Top holdings include UnitedHealth Group (20.61%), CVS Health, and Elevance Health.
Can Cigna's Smart Coverage Help Close Health-Cost Gaps?
Cigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.